Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Sphere- Treatment of Persistent Atrial Fibrillation with the Sphere -9- mapping and ablation cathether and the AFFERA Mapping and Ablation system

Disease Sites:

Not Available

Staging:

Phase II

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Richardson, Travis

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

04-14-2022

Trial Type:

Treatment

Protocol ID:

CRE-ARR0015

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available